310 research outputs found
The melting performance of single screw extruders
A number of recent screw designs is analyzed for melting performance, using a simple analytical approach based on Tadmor's original work. The melting length for a screw with constant depth channel is used as reference. An ideal compression screw will have a melting length of one-half the melting length of the reference screw. The Maillefer melt separation principle is discussed. The Maillefer screw melts in 2/3 of the length of the reference screw. Screws by Barr, by Dray and Lawrence and by Kim are shown to approach the ideal compression screw. A new design screw, using ideal compression and multiple channels and having a very large screw pitch, is shown to be a considerably more efficient melting device than any of the other, screws discussed
Brittle-tough transition in nylon-rubber blends: effect of rubber concentration and particle size
Blends of nylon-6 and EPDM-rubber were prepared with various rubber contents (0â20 wt%) and particle sizes (0.3â1.6 ÎŒm). The effects of rubber concentration and particle size on the tensile modulus, torsion modulus, yield stress and notched impact strength of the blends were studied. Blend structures and fracture surfaces were investigated by scanning electron microscopy. Rubber particles induce a sharp brittle-tough transition which is independent of the glass transition temperature of the nylon matrix. The brittle-tough transition temperature for notched Izod impact tests shifts to lower values when the rubber content is increased or the particle size is decreased. A correlation was found between the brittle-tough temperature and the interparticle distance. Two deformation modes were observed: voiding and shear yielding. Particle size and interfacial adhesion affect neither the yield stress nor the modulus of the blends
Online Publikationen (ohne Zs.) Titel: Johann Ingen-HouĂ K. K. Hofraths und Leibarztes, der Königl. Gesellschaft der Wissenschaften zu London ... Versuche mit Pflanzen, hauptsĂ€chlich ĂŒber die Eigenschaft, welche sie in einem hohen Grade besitzen, die Luft im Sonnenlichte zu reinigen, und in der Nacht und im Schatten zu verderben : nebst einer neuen Methode, den Grad der Reinheit und Heilsamkeit der atmosphĂ€rischen Luft zu prĂŒfen / aus dem Franz. ĂŒbers. von Johann Andreas Scherer
Einheitssachtitel: Experiments on Vegetables <dt.
Temperature development in the leakage flow of screw extruders
Temperature distribution at the exit of the leakage gap is of interest for a number of problems. For the calculation of temperatures, the leakage flow may be considered to be a pure drag flow to a good approximation. In the Newtonian case, thermal development length may be expressed in terms of gap height as L â 3/8Pe ·Ύ ;usually this is less than the available gap length. Pe is the Peclet number and ÎŽ the height of leakage gap. Therefore the existing flow may be considered fully developed. For power law fluids, numerical calculations lead to results of the same order. Martin's results therefore may be applied to the flow at the exit of the leakage gap
Antitumour necrosis factor-α therapy for hidradenitis suppurativa: results from a national cohort study between 2000 and 2013
International audienceHidradenitis suppurativa (HS) is a frequent chronic inflammatory skin disease typically characterized by recurrent painful, deep inflammatory nodules of the axillary, breast, groin and gluteal areas. European recommendations are mainly based on expert opinion. Drug treatments are heterogenous (e.g., antibiotics, corticosteroids, retinoids) and lack consensus among expert centres. The most severe disease forms or those failing to respond to conventional drugs may be associated with worsened functional prognosis. Anti-tumor necrosis factor α (anti-TNFα) drugs have been prescribed in these cases. The results of randomized controlled trials (RCTs) are discordant. Three RCTs concluded to the efficacy of adalimumab (ADA), and two others did not detect any difference between infliximab (IFX) or etanercept (ETA) and placebo. Finally, data from the literature and reported experiences do not conclude on the efficacy of anti-TNFα drugs for HS. This article is protected by copyright. All rights reserve
International multicentre observational study to assess the efficacy and safety of a 0·5 mg kgâ1 per day starting dose of oral corticosteroids to treat bullous pemphigoid
BackgroundEuropean guidelines propose a 0 center dot 5 mg kg(-1) per day dose of oral prednisone as initial treatment for bullous pemphigoid (BP). We assessed the safety and efficacy of this regimen depending on BP extent and general condition of the patients.MethodsIn a prospective international study, we consecutively included all patients diagnosed with BP. Patients received a 0 center dot 5 mg kg(-1) per day dose of prednisone, which was then gradually tapered 15 days after disease control, with the aim of stopping prednisone or maintaining minimal treatment (0 center dot 1 mg kg(-1) per day) within 6 months after the start of treatment. The two coprimary endpoints were control of disease activity at day 21 and 1-year overall survival. Disease severity was assessed according to the Bullous Pemphigoid Disease Area Index (BPDAI) score.ResultsIn total, 198 patients were included between 2015 and 2017. The final analysis comprised 190 patients with a mean age of 80 center dot 9 (SD 9 center dot 1) years. Control of disease activity was achieved at day 21 in 119 patients [62 center dot 6%, 95% confidence interval (CI) 55 center dot 3-69.5]; 18 of 24 patients (75%, 95% CI 53 center dot 3-90 center dot 2), 75 of 110 patients (68 center dot 8%, 95% CI 59 center dot 2-77 center dot 3) and 26 of 56 patients (46.4%, 95% CI 33 center dot 0-60 center dot 3) had mild, moderate and severe BP, respectively (P = 0 center dot 0218). A total of 30 patients died during the study. The overall Kaplan-Meier 1-year survival was 82 center dot 6% (95% CI 76 center dot 3-87 center dot 4) corresponding to 90 center dot 9%, 83 center dot 0% and 80 center dot 0% rates in patients with mild, moderate and severe BP, respectively (P = 0 center dot 5). Thresholds of 49 points for BPDAI score and 70 points for Karnofsky score yielded maximal Youden index values with respect to disease control at day 21 and 1-year survival, respectively.ConclusionsA 0 center dot 5 mg kg(-1) per day dose of prednisone is a valuable therapeutic option in patients with mild or moderate BP whose general condition allows them to be autonomous.</p
The red leg dilemma: a scoping review of the challenges of diagnosing lower limb cellulitis
Background: Suspected lower limb cellulitis presentations are commonly misdiagnoses, resulting in avoidable antibiotic prescribing or hospital admissions. Understanding the challenges posed in diagnosing cellulitis may help enhance future care.Objectives: To examine and map out the challenges and facilitators identified by patients and health professionals in diagnosing lower limb cellulitis.Methods: A scoping systematic review was performed in MEDLINE and Embase in October 2017. Thematic analysis was used to identify key themes. Quantitative data was summarised by narrative synthesis.Results: Three themes were explored: (i) clinical case reports of misdiagnosis, (ii) service development and (iii) diagnostic aids. Fortyâseven different pathologies were misdiagnosed, including seven malignancies. Two different services have been piloted to reduce the misdiagnosis rates of lower limb cellulitis and save costs. Four studies have looked at biochemical markers, imaging and a scoring tool to aid diagnosis.Conclusions: This review highlights the range of alternative pathologies that can be misdiagnosed as cellulitis, and emerging services and diagnostic aids developed to minimise misdiagnosis. Future work should focus on gaining a greater qualitative understanding of the diagnostic challenges from the perspective of patients and clinicians.This article is protected by copyright. All rights reserved
- âŠ